Prevalence of metabolic dysfunction associated fatty liver disease in people with type 1 diabetes

被引：0
|
作者：
Bellido, V. [1 ]
Amuedo, S. [1 ]
Remon-Ruiz, P. [1 ]
Roque-Cuellar, C. [1 ]
Jimenez-Sanchez, A. [1 ]
Gros-Herguido, N. [1 ]
Lopez-Gallardo, G. [1 ]
Pinar-Gutierrez, A. [1 ]
Soto-Moreno, A. [1 ]
机构：
[1] Hosp Univ Virgen Rocio, UGC Endocrinol & Nutr, Seville, Spain
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1045
引用
收藏
页码：S498 / S499
页数：2
相关论文
共 50 条
  • [41] Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes
    Wang, Yu-Jie
    Jin, Chun-Hua
    Ke, Jiang-Feng
    Wang, Jun-Wei
    Ma, Yi-Lin
    Lu, Jun-Xi
    Li, Mei-Fang
    Li, Lian-Xi
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 3717 - 3728
  • [42] Metabolic dysfunction-associated fatty liver disease and obesity can modify the inflammation and complement activation in type 2 diabetes
    Sipter, E.
    Barkai, L.
    Babayigit, K.
    Csuka, D.
    Prohaszka, Z.
    Hosszufalusi, N.
    DIABETOLOGIA, 2024, 67 : S312 - S312
  • [43] Metabolic dysfunction-associated fatty liver disease increases the risk of type 2 diabetes mellitus in young Korean adults
    Ha, Junchul
    Hong, Oak-Kee
    Han, Kyungdo
    Kwon, Hyuk-Sang
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 212
  • [44] The prevalence of metabolic dysfunction-associated fatty liver disease and its association on adverse pregnancy outcomes in women with gestational diabetes mellitus
    Chai, Thora Y.
    Deng, Difei
    Byth, Karen
    George, Jacob
    Pasupathy, Dharmintra
    Cheung, Ngai Wah
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 191
  • [45] Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Stefan, Norbert
    Roden, Michael
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 : S290 - S296
  • [46] Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults
    Liu, Jiaye
    Ayada, Ibrahim
    Zhang, Xiaofang
    Wang, Ling
    Li, Yang
    Wen, Tianfu
    Ma, Zhongren
    Bruno, Marco J.
    de Knegt, Robert J.
    Cao, Wanlu
    Peppelenbosch, Maikel P.
    Ghanbari, Mohsen
    Li, Zhihui
    Pan, Qiuwei
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (03) : E573 - E582
  • [47] THE PREVALENCE AND SEVERITY OF METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN THE VA PRIMARY CARE SETTING
    Thrift, Aaron P.
    Kanwal, Fasiha
    Loomba, Rohit
    Ramsey, David
    El-Serag, Hashem B.
    GASTROENTEROLOGY, 2021, 160 (06) : S671 - S671
  • [48] LIVER FIBROSIS IN ASIANS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE
    Kim, Byung Ik
    Sohn, Won
    Kwon, Heon-Ju
    Cho, Yong Kyun
    HEPATOLOGY, 2021, 74 : 1022A - 1022A
  • [49] Liver Fibrosis in Asians With Metabolic Dysfunction-Associated Fatty Liver Disease
    Sohn, Won
    Kwon, Heon-Ju
    Chang, Yoosoo
    Ryu, Seungho
    Cho, Yong Kyun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (05) : E1135 - E1148
  • [50] Prevalence of metabolic dysfunction-associated fatty liver disease among information technology employees in India
    Bhargava, Bharam
    Rao, Padaki Nagaraja
    Kulkarni, Anand V.
    Vishnubhotla, Ravikanth
    Pramod, Nanditha
    Anitha, Chandanadur Thippaiah
    Mahadev, Kalyankar
    SCIENTIFIC REPORTS, 2025, 15 (01):
12345